| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8541672 | Journal of Pharmacy Research | 2013 | 4 Pages | 
Abstract
												This study concludes that CURB-65 is not utilized in the way it should be when dealing with pneumonia patients. It is recommended that hospital administrations take action in the follow up process in order to prevent individual decisions made by physicians.
											Related Topics
												
													Health Sciences
													Pharmacology, Toxicology and Pharmaceutical Science
													Pharmacology, Toxicology and Pharmaceutics (General)
												
											Authors
												Muaed Jamal Alomar, Mohammad Majed Al-Ahmad, 
											